Ferenc Boldizsár

9PUBLICATIONS
11CO-AUTHORS
Molecular targetsAutoimmunityTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2025
Proteasome Inhibitors: Potential in Rheumatoid Arthritis Therapy?

Oktávia Tarjányi, Katalin Olasz, Fanni Rátky

|Nov 09, 2024
The Spleen Modulates the Balance of Natural and Pathological Autoantibodies in a Mouse Model of Autoimmune Arthritis.

Katalin Olasz, Szonja Gál, Esam Khanfar

|May 16, 2024
Recombinant Human Proteoglycan Aggrecan-G1 Domain-induced Arthritis (GIA) Mouse Model.

Katalin Olasz, Ferenc Boldizsar

|Feb 16, 2024
Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice.

Esam Khanfar, Katalin Olasz, Szonja Gál

|Jun 28, 2023
Natural and Pathological Autoantibodies Show Age-Related Changes in a Spontaneous Autoimmune Mouse (NZB) Model.

Szonja Gál, Erzsébet Gajdócsi, Esam Khanfar

|May 16, 2022
Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA.

Esam Khanfar, Katalin Olasz, Erzsébet Gajdócsi

Pageof 2